| Drug Name |
Exemestane |
| Drug ID |
BADD_D00861 |
| Description |
Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal women. It irreversibly binds to the active site of the enzyme resulting in permanent inhibition. |
| Indications and Usage |
For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. |
| Marketing Status |
Prescription |
| ATC Code |
L02BG06 |
| DrugBank ID |
DB00990
|
| KEGG ID |
D00963
|
| MeSH ID |
C056516
|
| PubChem ID |
60198
|
| TTD Drug ID |
D0D2VS
|
| NDC Product Code |
62157-091; 51991-005; 59057-007; 73377-132; 64918-0621; 50090-5193; 52128-134; 63629-2056; 59057-008; 69097-316; 0009-7663; 62756-981; 68382-383; 64181-0005; 0832-0595; 44278-025; 0378-5001; 65427-030; 71921-190; 46439-8746; 49386-026; 65162-240; 53104-7666; 47781-108; 59762-2858; 0054-0080; 65129-1217; 70771-1374; 64918-0622; 65089-0046 |
| Synonyms |
exemestane | examestane | 6-methyleneandrosta-1,4-diene-3,17-dione | FCE 24304 | FCE-24304 | Aromasil | Aromasin | Aromasine |
